Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data.

Vigers T, Chan CL, Snell-Bergeon J, Bjornstad P, Zeitler PS, Forlenza G, Pyle L.

PLoS One. 2019 Oct 11;14(10):e0216851. doi: 10.1371/journal.pone.0216851. eCollection 2019.

PMID:
31603912
2.

Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.

Potier L, Roussel R, Marre M, Bjornstad P, Cherney DZ, El Boustany R, Fumeron F, Venteclef N, Gautier JF, Hadjadj S, Mohammedi K, Velho G.

Diabetes Care. 2019 Oct 3. pii: dc191062. doi: 10.2337/dc19-1062. [Epub ahead of print]

PMID:
31582427
3.

Renal SGLT mRNA Expression in Human Health and Disease: A Study in Two Cohorts.

Srinivasan Sridhar V, Ambinathan JPN, Kretzler M, Pyle LL, Bjornstad P, Eddy S, Cherney DZI, Reich HN, The Ercb Group, The Neptune Group.

Am J Physiol Renal Physiol. 2019 Sep 23. doi: 10.1152/ajprenal.00370.2019. [Epub ahead of print]

PMID:
31545924
4.

Fructose tolerance test in obese people with and without type 2 diabetes.

Al-Ozairi E, Rivard CJ, Sanchez Lozada LG, Lanaspa MA, Bjornstad P, Al Salem D, Alhubail A, Megahed A, Kuwabara M, Johnson RJ, Asad RA.

J Diabetes. 2019 Aug 31. doi: 10.1111/1753-0407.12984. [Epub ahead of print]

PMID:
31472036
5.

Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes.

Wiromrat P, Bjornstad P, Vinovskis C, Chung LT, Roncal C, Pyle L, Lanaspa MA, Johnson RJ, Cherney DZ, Reznick-Lipina TK, Bishop F, Maahs DM, Wadwa RP.

Pediatr Diabetes. 2019 Aug 21. doi: 10.1111/pedi.12909. [Epub ahead of print]

PMID:
31433534
6.

The Role of Volume Regulation and Thermoregulation in AKI during Marathon Running.

Mansour SG, Martin TG, Obeid W, Pata RW, Myrick KM, Kukova L, Jia Y, Bjornstad P, El-Khoury JM, Parikh CR.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1297-1305. doi: 10.2215/CJN.01400219. Epub 2019 Aug 14.

PMID:
31413064
7.

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.

van Raalte DH, Bjornstad P, Persson F, Powell DR, de Cassia Castro R, Wang PS, Liu M, Heerspink HJL, Cherney D.

Diabetes Care. 2019 Oct;42(10):1921-1929. doi: 10.2337/dc19-0937. Epub 2019 Aug 1.

PMID:
31371432
8.

Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes.

Wiromrat P, Bjornstad P, Roncal C, Pyle L, Johnson RJ, Cherney DZ, Lipina T, Bishop F, Maahs DM, Wadwa RP.

J Diabetes Complications. 2019 Sep;33(9):648-650. doi: 10.1016/j.jdiacomp.2019.05.023. Epub 2019 Jun 3.

PMID:
31253490
9.

Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Scarr D, Bjornstad P, Lovblom LE, Lovshin JA, Boulet G, Lytvyn Y, Farooqi MA, Lai V, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Cherney DZI, Perkins BA.

Kidney Int Rep. 2019 Feb 21;4(6):786-796. doi: 10.1016/j.ekir.2019.02.010. eCollection 2019 Jun.

10.

Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report.

Bjornstad P, Lovshin JA, Lytvyn Y, Lovblom LE, Scarr D, Boulet G, Farooqi MA, Orszag A, Bai JW, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

J Diabetes Complications. 2019 Aug;33(8):547-549. doi: 10.1016/j.jdiacomp.2019.05.007. Epub 2019 May 17.

PMID:
31186164
11.

Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes.

Sekercioglu N, Lovblom LE, Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Farooqi MA, Orszag A, Lai V, Tse J, Cham L, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Ren Fail. 2019 Nov;41(1):427-433. doi: 10.1080/0886022X.2019.1614057.

12.

Serum uromodulin inversely associates with aortic stiffness in youth with type 1 diabetes: A brief report from EMERALD study.

Wiromrat P, Bjornstad P, Roncal C, Cree-Green M, Baumgartner A, Coe G, Reyes YG, Schäfer M, Truong U, Pyle L, Johnson RJ, Nadeau KJ.

J Diabetes Complications. 2019 Jun;33(6):434-436. doi: 10.1016/j.jdiacomp.2019.03.001. Epub 2019 Mar 21.

PMID:
31003921
13.

Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ; TODAY Study Group.

Diabetes Care. 2019 Jun;42(6):1120-1128. doi: 10.2337/dc18-2147. Epub 2019 Apr 9.

PMID:
30967435
14.

Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?

Scholtes RA, van Baar MJB, Lytvyn Y, Bjornstad P, Nieuwdorp M, Cherney DZI, van Raalte DH.

Diabetes Obes Metab. 2019 Apr;21 Suppl 2:24-33. doi: 10.1111/dom.13692. Review.

PMID:
30843294
15.

Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Am J Kidney Dis. 2019 Jun;73(6):786-796. doi: 10.1053/j.ajkd.2018.12.034. Epub 2019 Feb 22.

PMID:
30799029
16.

Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.

Lytvyn Y, Bjornstad P, Lovshin JA, Singh SK, Boulet G, Farooqi MA, Lai V, Tse J, Cham L, Lovblom LE, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Advani A, Sochett E, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Jun;21(6):1388-1398. doi: 10.1111/dom.13665. Epub 2019 Mar 28.

PMID:
30761725
17.

Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.

Bjornstad P, Schäfer M, Truong U, Cree-Green M, Pyle L, Baumgartner A, Garcia Reyes Y, Maniatis A, Nayak S, Wadwa RP, Browne LP, Reusch JEB, Nadeau KJ.

Circulation. 2018 Dec 18;138(25):2895-2907. doi: 10.1161/CIRCULATIONAHA.118.035525.

PMID:
30566007
18.

Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Lovshin JA, Lytvyn Y, Lovblom LE, Katz A, Boulet G, Bjornstad P, Lai V, Cham L, Tse J, Orszag A, Keenan HA, Paul N, Bril V, Wong DT, McReelis KD, Brent MH, Perkins BA, Cherney DZI.

Diabetes Care. 2019 Feb;42(2):273-280. doi: 10.2337/dc18-1809. Epub 2018 Dec 6.

PMID:
30523033
19.

Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.

Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZI, Wong R, Rewers MJ, Snell-Bergeon JK.

Diabetes Care. 2019 Feb;42(2):297-302. doi: 10.2337/dc18-1527. Epub 2018 Nov 27.

PMID:
30482755
20.

Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Bjornstad P, Eckel RH.

Curr Diab Rep. 2018 Oct 17;18(12):127. doi: 10.1007/s11892-018-1101-6. Review.

PMID:
30328521
21.

The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.

Bjornstad P, Singh SK, Snell-Bergeon JK, Lovshin JA, Lytvyn Y, Lovblom LE, Rewers MJ, Boulet G, Lai V, Tse J, Cham L, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Obes Metab. 2019 Mar;21(3):575-583. doi: 10.1111/dom.13556. Epub 2018 Nov 11.

PMID:
30311395
22.

Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Lovshin JA, Bjornstad P, Lovblom LE, Bai JW, Lytvyn Y, Boulet G, Farooqi MA, Santiago S, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Care. 2018 Dec;41(12):2570-2578. doi: 10.2337/dc18-1236. Epub 2018 Oct 1.

PMID:
30275283
23.

Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

León Jiménez D, Cherney DZI, Bjornstad P, Guerra LC, Miramontes González JP.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1406-F1415. doi: 10.1152/ajprenal.00384.2017. Epub 2018 Aug 1. Review.

PMID:
30066584
24.

Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study.

Jensen T, Bjornstad P, Johnson RJ, Sippl R, Rewers M, Snell-Bergeon JK.

Can J Diabetes. 2019 Feb;43(1):34-39. doi: 10.1016/j.jcjd.2018.03.006. Epub 2018 Mar 14.

PMID:
30026043
25.

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.

Bjornstad P, Laffel L, Tamborlane WV, Simons G, Hantel S, von Eynatten M, George J, Marquard J, Cherney DZI.

Diabetes Care. 2018 Aug;41(8):e129-e130. doi: 10.2337/dc18-0394. Epub 2018 Jun 25. No abstract available.

26.

Correction: Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study.

Kuwabara M, Hisatome I, Roncal-Jimenez CA, Niwa K, Andres-Hernando A, Jensen T, Bjornstad P, Milagres T, Cicerchi C, Song Z, Garcia G, Sánchez-Lozada LG, Ohno M, Lanaspa MA, Johnson RJ.

PLoS One. 2018 May 17;13(5):e0197941. doi: 10.1371/journal.pone.0197941. eCollection 2018.

27.

Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".

Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI.

Circulation. 2018 May 1;137(18):1984-1985. doi: 10.1161/CIRCULATIONAHA.117.033238. No abstract available.

28.

Experimental heat stress nephropathy and liver injury are improved by allopurinol.

Roncal-Jimenez CA, Sato Y, Milagres T, Andres Hernando A, García G, Bjornstad P, Dawson JB, Sorensen C, Newman L, Krisher L, Madero M, Glaser J, Gárcía-Trabanino R, Romero EJ, Song Z, Jensen T, Kuwabara M, Rodriguez-Iturbe B, Sanchez-Lozada LG, Lanaspa MA, Johnson RJ.

Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F726-F733. doi: 10.1152/ajprenal.00543.2017. Epub 2018 Apr 18.

29.

Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease.

Bjornstad P, Cherney DZ.

Curr Diab Rep. 2018 Mar 19;18(5):22. doi: 10.1007/s11892-018-0996-2. Review.

30.

Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots.

Bjornstad P, Karger AB, Maahs DM.

Adv Chronic Kidney Dis. 2018 Jan;25(1):76-83. doi: 10.1053/j.ackd.2017.09.003. Review.

31.

Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes.

Bjornstad P, Maahs DM, Roncal CA, Snell-Bergeon JK, Shah VN, Milagres T, Ellis SL, Hatch M, Chung LT, Rewers MJ, Garg S, Cherney DZ, Pyle L, Nadeau KJ, Johnson RJ.

Diabetes Obes Metab. 2018 Jul;20(7):1776-1780. doi: 10.1111/dom.13274. Epub 2018 Mar 24.

32.

Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?

Bjornstad P, Donaghue KC, Maahs DM.

Lancet Diabetes Endocrinol. 2018 Oct;6(10):809-820. doi: 10.1016/S2213-8587(18)30035-4. Epub 2018 Feb 20. Review. Erratum in: Lancet Diabetes Endocrinol. 2018 Apr 10;:.

33.

Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Bjornstad P, Lovshin JA, Lytvyn Y, Boulet G, Lovblom LE, Alhuzaim ON, Farooqi MA, Lai V, Tse J, Cham L, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.

Diabetes Care. 2018 Apr;41(4):831-839. doi: 10.2337/dc17-2475. Epub 2018 Feb 2.

34.

Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with Type 1 diabetes mellitus.

Lovshin JA, Škrtić M, Bjornstad P, Moineddin R, Daneman D, Dunger D, Reich HN, Mahmud F, Scholey J, Cherney DZI, Sochett E.

Am J Physiol Renal Physiol. 2018 Apr 1;314(4):F667-F674. doi: 10.1152/ajprenal.00400.2017. Epub 2017 Dec 13.

35.

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.

Tonneijck L, Muskiet MHA, Smits MM, Bjornstad P, Kramer MHH, Diamant M, Hoorn EJ, Joles JA, van Raalte DH.

Diabetes Obes Metab. 2018 May;20(5):1235-1245. doi: 10.1111/dom.13223. Epub 2018 Feb 20.

36.

Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Lovshin JA, Boulet G, Lytvyn Y, Lovblom LE, Bjornstad P, Farooqi MA, Lai V, Cham L, Tse J, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZ.

JCI Insight. 2018 Jan 11;3(1). pii: 96968. doi: 10.1172/jci.insight.96968. eCollection 2018 Jan 11.

37.

Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study.

Gidding SS, Bacha F, Bjornstad P, Levitt Katz LE, Levitsky LL, Lynch J, Tryggestad JB, Weinstock RS, El Ghormli L, Lima JAC; TODAY Study Group.

J Pediatr. 2018 Jan;192:86-92.e5. doi: 10.1016/j.jpeds.2017.09.012.

38.

Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.

Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato Y, Jensen T, Garcia G, Rodriguez-Iturbe B, Ohno M, Lanaspa MA, Johnson RJ.

Hypertension. 2018 Jan;71(1):78-86. doi: 10.1161/HYPERTENSIONAHA.117.10370. Epub 2017 Dec 4.

39.

Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.

Bjornstad P, Nehus E, El Ghormli L, Bacha F, Libman IM, McKay S, Willi SM, Laffel L, Arslanian S, Nadeau KJ; TODAY Study Group.

Am J Kidney Dis. 2018 Jan;71(1):65-74. doi: 10.1053/j.ajkd.2017.07.015. Epub 2017 Nov 20. Erratum in: Am J Kidney Dis. 2019 Apr;73(4):580.

40.

Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study.

Rajasekeran H, Reich HN, Hladunewich MA, Cattran D, Lovshin JA, Lytvyn Y, Bjornstad P, Lai V, Tse J, Cham L, Majumder S, Bowskill BB, Kabir MG, Advani SL, Gibson IW, Sood MM, Advani A, Cherney DZI.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F412-F422. doi: 10.1152/ajprenal.00445.2017. Epub 2017 Nov 15.

42.

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Lytvyn Y, Bjornstad P, Udell JA, Lovshin JA, Cherney DZI.

Circulation. 2017 Oct 24;136(17):1643-1658. doi: 10.1161/CIRCULATIONAHA.117.030012. Review.

43.

Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.

Bjornstad P, Pyle L, Cherney DZI, Johnson RJ, Sippl R, Wong R, Rewers M, Snell-Bergeon JK.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1189-1196. doi: 10.1093/ndt/gfx255.

44.

"Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study.

Kuwabara M, Kuwabara R, Hisatome I, Niwa K, Roncal-Jimenez CA, Bjornstad P, Andres-Hernando A, Sato Y, Jensen T, Garcia G, Ohno M, Hill JO, Lanaspa MA, Johnson RJ.

Obesity (Silver Spring). 2017 Nov;25(11):1997-2008. doi: 10.1002/oby.22000. Epub 2017 Sep 18.

45.

Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.

Bjornstad P, Costacou T, Miller RG, Maahs DM, Rewers MJ, Orchard TJ, Snell-Bergeon JK.

Diabet Med. 2017 Nov;34(11):1532-1540. doi: 10.1111/dme.13430. Epub 2017 Aug 14.

46.

Kidney Function Can Predict Pregnancy Outcomes.

Bjornstad P, Cherney DZI.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1029-1031. doi: 10.2215/CJN.04970517. Epub 2017 Jun 13. No abstract available.

47.

Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.

Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, Bjornstad P, Jensen T, Sato Y, Milagres T, Garcia G, Ohno M, Lanaspa MA, Johnson RJ.

Hypertension. 2017 Jun;69(6):1036-1044. doi: 10.1161/HYPERTENSIONAHA.116.08998. Epub 2017 Apr 10.

48.

Leptin is associated with cardiopulmonary fitness independent of body-mass index and insulin sensitivity in adolescents with type 1 diabetes: a brief report from the EMERALD study.

Bjornstad P, Cree-Green M, Baumgartner A, Coe G, Reyes YG, Schafer M, Pyle L, Regensteiner JG, Reusch JEB, Nadeau KJ.

J Diabetes Complications. 2017 May;31(5):850-853. doi: 10.1016/j.jdiacomp.2017.02.019. Epub 2017 Mar 14.

49.

Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.

Kuwabara M, Bjornstad P, Hisatome I, Niwa K, Roncal-Jimenez CA, Andres-Hernando A, Jensen T, Milagres T, Sato Y, Garcia G, Ohno M, Lanaspa MA, Johnson RJ.

Am J Nephrol. 2017;45(4):330-337. doi: 10.1159/000464260. Epub 2017 Mar 11.

50.

Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study.

Kuwabara M, Hisatome I, Roncal-Jimenez CA, Niwa K, Andres-Hernando A, Jensen T, Bjornstad P, Milagres T, Cicerchi C, Song Z, Garcia G, Sánchez-Lozada LG, Ohno M, Lanaspa MA, Johnson RJ.

PLoS One. 2017 Jan 12;12(1):e0169137. doi: 10.1371/journal.pone.0169137. eCollection 2017. Erratum in: PLoS One. 2018 May 17;13(5):e0197941.

Supplemental Content

Loading ...
Support Center